Imipramine | CAS#50-49-7 | tricyclic antidepressant

MedKoo Cat#: 596105 | Name: Imipramine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Imipramine is a tricyclic antidepressant.

Chemical Structure

Imipramine

CAS#50-49-7 (free base)

Theoretical Analysis

MedKoo Cat#: 596105

Name: Imipramine

CAS#: 50-49-7 (free base)

Chemical Formula: C19H24N2

Exact Mass: 280.1939

Molecular Weight: 280.41

Elemental Analysis: C, 81.38; H, 8.63; N, 9.99

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

113-52-0 (HCl) 50-49-7 (free base)

Synonym

Imipramine; Dimipressin; EINECS 200-042-1; HSDB 3100; HSDB3100; HSDB-3100; Melipramine; BRN 0256892; BRN-0256892; BRN0256892; NSC 169866; NSC-169866; NSC169866; Pryleugan; Tofranil; Dyna-zina;

IUPAC/Chemical Name

3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

InChi Key

BCGWQEUPMDMJNV-UHFFFAOYSA-N

InChi Code

InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3

SMILES Code

CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 280.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Agabio R, Trogu E, Pani PP. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Database Syst Rev. 2018 Apr 24;4:CD008581. doi: 10.1002/14651858.CD008581.pub2. Review. PubMed PMID: 29688573. 2: Wang Z, Whiteside S, Sim L, Farah W, Morrow A, Alsawas M, Moreno PB, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Gunjal S, Mantilla LL, Ponte OP, LeBlanc A, Prokop LJ, Murad MH. Anxiety in Children [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Aug. Available from http://www.ncbi.nlm.nih.gov/books/NBK476277/ PubMed PMID: 29360312. 3: Shafiee M, Arekhi S, Omranzadeh A, Sahebkar A. Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. J Affect Disord. 2018 Feb;227:330-337. doi: 10.1016/j.jad.2017.11.020. Epub 2017 Nov 7. Review. PubMed PMID: 29136602. 4: Swedish Council on Health Technology Assessment. Treatment of Anxiety Disorders: A Systematic Review [Internet]. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2005 Nov. Available from http://www.ncbi.nlm.nih.gov/books/NBK447974/ PubMed PMID: 28876726. 5: Crocq MA. The history of generalized anxiety disorder as a diagnostic category. Dialogues Clin Neurosci. 2017 Jun;19(2):107-116. Review. PubMed PMID: 28867935; PubMed Central PMCID: PMC5573555. 6: Shamim D, Laskowski M. Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor α Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease. J Cent Nerv Syst Dis. 2017 Jul 28;9:1179573517722512. doi: 10.1177/1179573517722512. eCollection 2017. Review. PubMed PMID: 28811745; PubMed Central PMCID: PMC5536370. 7: Euwema MS, Swanson TJ. Toxicity, Deadly Single Dose Agents. 2017 Oct 6. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK441849/ PubMed PMID: 28722879. 8: Turner AL, Perry MS. Outside the box: Medications worth considering when traditional antiepileptic drugs have failed. Seizure. 2017 Aug;50:173-185. doi: 10.1016/j.seizure.2017.06.022. Epub 2017 Jun 27. Review. PubMed PMID: 28704741. 9: Ulrich S, Ricken R, Adli M. Tranylcypromine in mind (Part I): Review of pharmacology. Eur Neuropsychopharmacol. 2017 Aug;27(8):697-713. doi: 10.1016/j.euroneuro.2017.05.007. Epub 2017 Jun 24. Review. PubMed PMID: 28655495. 10: Undurraga J, Baldessarini RJ. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. J Psychopharmacol. 2017 Sep;31(9):1184-1189. doi: 10.1177/0269881117711709. Epub 2017 Jun 21. Review. PubMed PMID: 28633600. 11: Dean L. Imipramine Therapy and CYP2D6 and CYP2C19 Genotype. 2017 Mar 23. In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-. Available from http://www.ncbi.nlm.nih.gov/books/NBK425164/ PubMed PMID: 28520379. 12: Orgeta V, Tabet N, Nilforooshan R, Howard R. Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis. J Alzheimers Dis. 2017;58(3):725-733. doi: 10.3233/JAD-161247. Review. PubMed PMID: 28505970; PubMed Central PMCID: PMC5467718. 13: Demontis F, Serra F, Serra G. Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness. Curr Neuropharmacol. 2017 Apr;15(3):417-423. doi: 10.2174/1570159X14666160715165648. Review. PubMed PMID: 28503114; PubMed Central PMCID: PMC5405612. 14: Dhir A. Investigational drugs for treating major depressive disorder. Expert Opin Investig Drugs. 2017 Jan;26(1):9-24. doi: 10.1080/13543784.2017.1267727. Epub 2016 Dec 14. Review. PubMed PMID: 27960559. 15: Galizia I, Oldani L, Macritchie K, Amari E, Dougall D, Jones TN, Lam RW, Massei GJ, Yatham LN, Young AH. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database Syst Rev. 2016 Oct 10;10:CD011286. Review. PubMed PMID: 27727432. 16: Jain S, Bhatt GC. Advances in the management of primary monosymptomatic nocturnal enuresis in children. Paediatr Int Child Health. 2016 Feb;36(1):7-14. doi: 10.1179/2046905515Y.0000000023. Epub 2015 May 2. Review. PubMed PMID: 25936863. 17: Abdel-Hamid IA, Elsaied MA, Mostafa T. The drug treatment of delayed ejaculation. Transl Androl Urol. 2016 Aug;5(4):576-91. doi: 10.21037/tau.2016.05.05. Review. PubMed PMID: 27652229; PubMed Central PMCID: PMC5001980. 18: Henssler J, Bschor T, Baethge C. Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients. Can J Psychiatry. 2016 Jan;61(1):29-43. doi: 10.1177/0706743715620411. Epub 2016 Jan 1. Review. PubMed PMID: 27582451; PubMed Central PMCID: PMC4756602. 19: Sinha R, Raut S. Management of nocturnal enuresis - myths and facts. World J Nephrol. 2016 Jul 6;5(4):328-38. doi: 10.5527/wjn.v5.i4.328. Review. PubMed PMID: 27458562; PubMed Central PMCID: PMC4936340. 20: Berry-Bibee EN, Kim MJ, Simmons KB, Tepper NK, Riley HE, Pagano HP, Curtis KM. Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review. Contraception. 2016 Dec;94(6):650-667. doi: 10.1016/j.contraception.2016.07.011. Epub 2016 Jul 18. Review. PubMed PMID: 27444984.